Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 13 chart positions in 13 markets.
By chart position
- 🇦🇺AU · Medicine#1865K to 30K
- 🇧🇷BR · Medicine#2930K to 100K
- 🇰🇷KR · Medicine#7710K to 30K
- 🇫🇷FR · Medicine#8910K to 30K
- 🇨🇴CO · Medicine#553K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
34K to 119K🎙 Weekly cadence·111 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
67K to 238K🇧🇷42%🇦🇺13%🇰🇷13%+10 more - Active Followers
Loyal subscribers who consistently listen
27K to 95K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHost
Recent guests
Recent episodes
ENP111: Addressing the Endocrine Workforce Shortage
Feb 25, 2026
30m 12s
ENP110: Hypercortisolism and T2D
Jan 21, 2026
20m 03s
ENP109: Anti-Obesity Medications (CME credit available)
Jan 7, 2026
13m 15s
ENP108: AI and Robotics in Surgery
Dec 17, 2025
10m 28s
ENP107: Compounded Obesity Medications
Dec 3, 2025
11m 49s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 2/25/26 | ![]() ENP111: Addressing the Endocrine Workforce Shortage✨ | endocrine workforce shortageadvanced practice providers+4 | Sara R. MacLeod, DO, MPHShannon K. Idzik, DNP, CRNP, ANP-BC, FAANP, FAAN | Clinical Advantage: Endocrinology Certificate for Advanced Practice ProvidersEndocrine Society+1 | — | endocrinologyworkforce shortage+5 | — | 30m 12s | |
| 1/21/26 | ![]() ENP110: Hypercortisolism and T2D✨ | hypercortisolismtype 2 diabetes+3 | Vivian A. Fonseca, MDJames W. Findling, MD | Endocrine SocietyDiabetes Care+1 | — | hypercortisolismtype 2 diabetes+5 | Corcept Therapeutics Inc. | 20m 03s | |
| 1/7/26 | ![]() ENP109: Anti-Obesity Medications (CME credit available)✨ | anti-obesity medicationspharmacological approaches+3 | Gitanjali Srivastava, MD | Vanderbilt University Medical CenterEndocrine Society | — | anti-obesitymedications+3 | Lilly | 13m 15s | |
| 12/17/25 | ![]() ENP108: AI and Robotics in Surgery✨ | artificial intelligencerobotics+4 | Hassan M. Heshmati, MD | Endocrine SocietyEndocrinology Metabolism Consulting | — | AIrobotics+5 | — | 10m 28s | |
| 12/3/25 | ![]() ENP107: Compounded Obesity Medications✨ | obesity medicationsGLP-1 drugs+3 | Michael Weintraub, MD | NYU Langone Division of EndocrinologyAmerican Board of Obesity Medicine | — | GLP-1obesity+5 | Lilly | 11m 49s | |
| 11/12/25 | ![]() ENP106: Reversing Bariatric Surgery✨ | bariatric surgeryobesity management+3 | Katherine Hazen, MD | University of Rochester Medical Center | — | bariatric surgeryobesity+3 | — | 12m 28s | |
| 10/29/25 | ![]() ENP105: Tirzepatide and Menopause✨ | tirzepatidemenopause+3 | Maria Daniela Hurtado Andrade, MD, PhDRegina Castaneda, MD | tirzepatideMayo Clinic Florida+1 | — | tirzepatidemenopause+3 | — | 18m 36s | |
| 10/15/25 | ![]() ENP104: Hidden Ingredients in Supplements✨ | supplementsendocrine health+3 | Meghana Pattipati, MD | Ochsner Lafayette General Medical CenterFood and Drug Administration | San Francisco | supplementsFDA+3 | — | 10m 47s | |
| 10/1/25 | ![]() ENP103: Type 1 Diabetes: Immunotherapies and Early Detection✨ | Type 1 DiabetesImmunotherapies+3 | Desmond Schatz | Endocrine Society | — | Type 1 DiabetesImmunotherapies+3 | Abbott Diabetes Care | 23m 20s | |
| 9/17/25 | ![]() ENP102: Insulin Delivery Systems (CME credit available)✨ | type 1 diabetesinsulin delivery systems+3 | Grazia Aleppo, MDDiana Isaacs, PharmD | Northwestern University’s Feinberg School of MedicineCleveland Clinic | — | insulin deliverytype 1 diabetes+3 | MannKind Corp. | 31m 56s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 9/3/25 | ![]() ENP101: Papillary Thyroid Cancer | No description provided. | 9m 52s | ||||||
| 8/13/25 | ![]() ENP100: Growth Hormone Deficiency | No description provided. | 16m 35s | ||||||
| 7/9/25 | ![]() ENP99: Fracture Liaison Services | No description provided. | 19m 17s | ||||||
| 3/19/25 | ![]() ENP98: Opioids and the Endocrine System | No description provided. | 17m 13s | ||||||
| 2/12/25 | ![]() ENP97: Childhood Obesity Treatment | No description provided. | 26m 04s | ||||||
| 12/18/24 | ![]() ENP96: Automated Insulin Delivery Systems | There is a lot of interest in automated insulin delivery systems, and they were covered in depth at the Endocrine Society’s Type 1 Diabetes Fellows Series, held earlier this year. Joining host Aaron Lohr to talk about these delivery systems is Grazia Aleppo, MD, a professor of medicine at Northwestern University and a presenter at the T1D Fellows Series. Show notes are available at https://www.endocrine.org/podcast/enp96-automated-insulin-delivery-systems — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 19m 13s | ||||||
| 12/4/24 | ![]() ENP95: Environmental Impact on Early Female Puberty | There are plenty of studies showing that chemicals found in the environment can directly impact human health. Some new research finds that certain environmental compounds may trigger early female puberty. Joining host Aaron Lohr to talk about that research is Natalie Shaw, MD, a Lasker clinical research scholar and principal investigator of the pediatric neuroendocrinology group in the Clinical Research Branch of the National Institute of Environmental Health Sciences. Dr. Shaw and colleagues authored an article recently published in the journal Endocrinology titled, “Identification of Environmental Compounds That May Trigger Early Female Puberty by Activating Human GnRHR and KISS1R.” Show notes are available at https://www.endocrine.org/podcast/enp95-environmental-impact-on-early-female-puberty — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 9m 07s | ||||||
| 11/13/24 | ![]() ENP94: Update on Acromegaly | It’s been a few years, but we are here with an update on acromegaly, covering prevalence, diagnosis, traditional treatment, new therapies, and current gaps in understanding. Host Aaron Lohr talks again with Maria Fleseriu, MD, professor of medicine and professor of neurological surgery at Oregon Health & Science University School of Medicine and director of OHSU’s Pituitary Center. Dr. Fleseriu also serves on the Board of Directors of the Endocrine Society. Show notes are available at https://www.endocrine.org/podcast/enp94-update-on-acromegaly — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 34m 23s | ||||||
| 10/16/24 | ![]() ENP93: Prioritizing Patient Experience in Managing Diabetes | Host Aaron Lohr talks with Rita Kalyani, MD, professor of medicine at Johns Hopkins University School of Medicine and president-elect of medicine and science at the American Diabetes Association. Earlier this year, Dr. Kalyani and colleagues published a position statement in The Journal of Clinical Endocrinology & Metabolism titled, “Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement.” Show notes are available at https://www.endocrine.org/podcast/enp93-patience-experience-in-managing-diabetes — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 27m 28s | ||||||
| 10/2/24 | ![]() ENP92: Pheochromocytomas | In this episode, we talk about pheochromocytomas. Host Aaron Lohr talks with Nikhitha Chandrashekar, MD, who recently finished her endocrinology fellowship at University Hospitals Case Western Reserve University in Cleveland. Dr. Chandrashekar presented a case study on pheochromocytomas at ENDO 2024. Show notes are available at https://www.endocrine.org/podcast/enp92-pheochromocytomas — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 12m 00s | ||||||
| 9/18/24 | ![]() ENP91: Hypothyroidism and Muscle Regeneration | Our bodies typically do a remarkable job of recovering from certain injuries, and thyroid hormone signaling has an essential role to play there. But what is that process like for someone with hypothyroidism, and is there a unique role in that process for muscle stem cells? Host Aaron Lohr talks with Paola Aguiari, PhD, a senior research specialist at Children’s Hospital Los Angeles. She presented an abstract at ENDO 2024 titled, “Hypothyroidism Impairs Skeletal Muscle Regeneration After Injury.” Show notes are available at https://www.endocrine.org/podcast/enp91-hypothyroidism-and-muscle-regeneration — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 11m 24s | ||||||
| 9/4/24 | ![]() ENP90: Early Life Stress and Substance Use | We all know that stress leads to a number of negative outcomes. In this episode, we talk about how early life stress may influence youth substance use initiation and some endocrine factors that may be helping to drive that influence. Host Aaron Lohr talks with Alexandra M. Donovan, PhD, of the Charles R. Drew University of Medicine and Science. Dr. Donovan recently presented an abstract at ENDO 2024 titled, “Early Life Stress and Pubertal Predictors of Youth Substance Use Initiation: Does Sex Moderate the Relationship Between Early Life Stress, Puberty, and Substance Use Initiation?” Show notes are available at https://www.endocrine.org/podcast/enp90-early-life-stress-and-substance-use — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 25m 01s | ||||||
| 8/21/24 | ![]() ENP89: Brown Fat and Metabolic Function | In this episode, we talk about brown fat and some new discoveries in how it regulates metabolic function. Joining host Aaron Lohr is Marsel Lino, PhD, a research fellow at Joslin Diabetes Center in Boston. Dr. Lino presented an abstract at ENDO 2024 titled, “A New Layer of Endocrine Regulation: Brown Fat Secretes Exosomal MicroRNAs, Which Regulate Metabolic Functions and Distal Organs.” Show notes are available at https://www.endocrine.org/podcast/enp89-brown-fat-and-metabolic-function — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 15m 36s | ||||||
| 8/7/24 | ![]() ENP88: Glucocorticoids in Supplements | Many people take over-the-counter supplements for a variety of reasons, but it isn’t always clear what’s in those supplements. And while they may be intended to help, some may cause harm. In this episode, host Aaron Lohr talks with Kevin Wei, MD, from the University of Southern California/Los Angeles General Medical Center Internal Medicine Residency Program about the presence of glucocorticoids in some over-the counter supplements and why that may be a concern. Dr. Wei and colleagues presented an abstract at ENDO 2024 titled, “Characterizing the Physiological Side Effects of Over-the-Counter Arthritis Supplements.” Show notes are available at https://www.endocrine.org/podcast/enp88-glucocorticoids-in-supplements — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 14m 20s | ||||||
| 7/24/24 | ![]() ENP87: Short-Term Weight Loss in Adolescents With Obesity | For those of us who try to lose weight at some point in time, we know the frustration of losing weight and feeling good about that, only to see that weight return. Why does that happen? Is the process the same for adults and adolescents? Is there any way to mitigate that weight regain? Joining host Aaron Lohr is Eric Bomberg, MD, assistant professor at the Center for Pediatric Obesity Medicine at the University of Minnesota. Dr. Bomberg recently presented an abstract at ENDO 2024 titled, “Hormonal and Physiological Changes Following Short-Term Weight Loss in Adolescents With Obesity and the Role of Glucagon-Like Peptide 1 Receptor Agonist to Counteract Adaptations.” Show notes are available at https://www.endocrine.org/podcast/enp87-short-term-weight-loss-in-adolescents-with-obesity — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast | 14m 11s | ||||||
Showing 25 of 109
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
14 placements across 13 markets.
Chart Positions
14 placements across 13 markets.

























